Matthew W. Tikonoff

Phone617.348.1619

Peer Rating
N/R
 N/R

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials
 

Practice Areas

  • Corporate & Securities
  • Mergers & Acquisitions
  • Securities & Capital Markets
  • Private Equity
  • Life Sciences
  • Retail & Consumer Products
  • Technology
  • Communications & Media
 
Contact InfoTelephone: 617.348.1619
Fax: 617-542-2241
Internet: Each Attorney's Internet Address takes the following form: first initial, last name @mintz.com (e.g., rmintz@mintz.com)

http://www.mintz.com/professionals/detail/name/matthew-w-tikonoff
 
University Boston College, B.A.
 
Law SchoolSuffolk University, J.D., magna cum laude
 
Admitted2007, Massachusetts
 
BornWinchester, Massachusetts, February 23, 1979
 
Biography

Matt represents public and private companies and private equity firms in a broad range of transactions and corporate matters. His practice focuses primarily on mergers and acquisitions, capital markets transactions, securities law compliance and general corporate representation. Matt has served as counsel for clients in a number of sectors, including life sciences, telecommunications, retail, higher education and technology.

Before joining Mintz Levin, Matt was an associate at an international law firm. During law school, he served as Articles Editor of the Suffolk University Law Review.

Representative Matters

• Essilor International SA in its acquisition of Costa Inc. (NASDAQ: ATX)

• FGX International Inc. in its acquisition of Stylemark

• Dynasil Corporation of America (NASDAQ: DYSL) in the sale of its cancer medical probe business to Dilon Technologies

• Dynasil Corporation of America (NASDAQ: DYSL) in the sale of its x-ray fluorescence lead paint detector business to Protec SA

• PTC Inc. (NASDAQ: PTC) in its acquisition of Enigma Information Systems Ltd.

• Ampersand Capital Partners in its acquisitions of numerous portfolio companies, including Blue Sky Biotech, Modified Polymer Components, ATS Labs and clinical toxicology companies

• Stemline Therapeutics, Inc. in its initial public offering

• Lamar Advertising Company (NASDAQ: LAMR) in Rule 144A debt offerings and follow-on exchange offers

 
Reported CasesRepresentative Matters: Essilor International SA in its acquisition of Costa Inc. (NASDAQ: ATX); FGX International Inc. in its acquisition of Stylemark; Dynasil Corporation of America (NASDAQ: DYSL) in the sale of its cancer medical probe business to Dilon Technologies; Dynasil Corporation of America (NASDAQ: DYSL) in the sale of its x-ray fluorescence lead paint detector business to Protec SA; PTC Inc. (NASDAQ: PTC) in its acquisition of Enigma Information Systems Ltd.; Ampersand Capital Partners in its acquisitions of numerous portfolio companies, including Blue Sky Biotech, Modified Polymer Components, ATS Labs and clinical toxicology companies; Stemline Therapeutics, Inc. in its initial public offering; Lamar Advertising Company (NASDAQ: LAMR) in Rule 144A debt offerings and follow-on exchange offers
 
ISLN919872521
 
Profile Visibility
#570 in weekly profile views out of 19,418 lawyers in Boston, Massachusetts
#42,688 in weekly profile views out of 1,587,858 total lawyers Overall

Office Information

Matthew W. Tikonoff


BostonMA 02111




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now